COVID-19

Open Access
Seroepidemiological Observational Study in Total and Neutralizing Antibodies to SARS-CoV-2 Among Primary Care Patients in Crete, Greece
ZOI POURNARA, EMMANOUELA KISSANDRAKI, SEVASTI KOURSIOTI, MANOLIS LINARDAKIS, EMMANOUIL K. SYMVOULAKIS, MARILENNA ANASTASAKI, CHRISTOS D. LIONIS and GEORGE SOURVINOS

In Vivo March 2026, 40 (2) 1207-1219; DOI: https://doi.org/10.21873/invivo.14276
Open Access
Pharmacogenomic Insights: The Role of CYP2D6 Allelic Variants in Drug Metabolism Among COVID-19 Patients With Comorbidities
MERT ÖZEN, ALTEN OSKAY, İBRAHIM TÜRKÇÜER, ATAKAN YILMAZ, MURAT SEYIT, YASEMIN ADALI, VEFA ÇAKMAK and AYLIN KÖSELER

In Vivo November 2025, 39 (6) 3563-3574; DOI: https://doi.org/10.21873/invivo.14154
Open Access
Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir
YUTA NAKAMARU, KEN-ICHI SAKO, NAOHITO IDE, YOSHIKAZU MATSUDA, FUMIYOSHI YAMASHITA and TOMOJI MAEDA

In Vivo July 2025, 39 (4) 2101-2108; DOI: https://doi.org/10.21873/invivo.14005
Open Access
Impact of the COVID-19 Pandemic on Ophthalmologists Residents Well-being and Training Programs: A Systematic Review
VASILIKI DIMAKI, CHRISTOS P. ZAMPETIDIS, EFTHIMIOS VASILOPOULOS, DIMITRIOS PAPAKONSTANTINOU, KLIO CHATZISTEFANOU and MARILITA M. MOSCHOS

In Vivo March 2025, 39 (2) 621-633; DOI: https://doi.org/10.21873/invivo.13867
Open Access
Prolonged Viral Shedding of SARS-CoV-2 in Patients With Underlying Haemato-oncological Disease
ALEXANDER CASIMIR ANGLEITNER, LENA LEVIEN and JUDITH BÜNTZEL

In Vivo March 2025, 39 (2) 844-850; DOI: https://doi.org/10.21873/invivo.13887
Open Access
Changes in miRNA Pattern Expression Associated With COVID-19 Severity
PAOLA B. ZÁRATE-SEGURA, MACARIO MARTÍNEZ-CASTILLO, AARÓN PARIS GARDUÑO-GUTIÉRREZ, J. MANUEL HERNÁNDEZ-HERNÁNDEZ, LUIS JAVIER CANO-MARTÍNEZ, JAIME GARCÍA-MENA, RAMÓN M. CORAL-VÁZQUEZ and FERNANDO BASTIDA-GONZÁLEZ

In Vivo January 2025, 39 (1) 482-490; DOI: https://doi.org/10.21873/invivo.13852
Open Access
A Time-varying Analysis of General Practice Prescribing in the COVID-19 Era: Lessons from Prescription Dynamics in a Pandemic
KINAN MOKBEL, KATE EMBLIN, ROB DANIELS, FAHAD ALGHAMDI and LEIGH JACKSON

In Vivo January 2025, 39 (1) 498-508; DOI: https://doi.org/10.21873/invivo.13854
Open Access
Hyperexpression of PTAFR and PF4 as Possible Platelet Risk Biomarkers in Patients With COVID-19
LÍVIA DE OLIVEIRA SALES, JEAN BRENO SILVEIRA DA SILVA, FLÁVIA MELO CUNHA DE PINHO PESSOA, BEATRIZ MARIA DIAS NOGUEIRA, LAIS LACERDA BRASIL DE OLIVEIRA, ANDRÉ SALIM KHAYAT, MANOEL ODORICO DE MORAES FILHO, MARIA ELISABETE AMARAL DE MORAES, RAQUEL CARVALHO MONTENEGRO and CAROLINE AQUINO MOREIRA-NUNES

In Vivo November 2024, 38 (6) 2853-2863; DOI: https://doi.org/10.21873/invivo.13766
Open Access
Long-term Impacts of Long COVID: Increased Incidence of Cardiomyopathies, Joint Diseases, and Psychoanxiety Disorders
ANDRADA FLORINA MOLDOVAN, TIMEA CLAUDIA GHITEA, KATALIN BABEȘ and FELICIA MANOLE

In Vivo November 2024, 38 (6) 3022-3032; DOI: https://doi.org/10.21873/invivo.13786
Open Access
Impact of PEG-GCSF in Breast Cancer Patients Undergoing Chemotherapy During the COVID-19 Pandemic: Single Center Experience and Literature Review
KIOTO YOKOYAMA, NOBUYASU YOSHIMOTO, SATORU TAKAYAMA, MASAKI SAKAMOTO, KEISUKE TOMODA, KEN ISHIKAWA, MASAKATSU YAMASHITA, HIROTO SUZUKI, RYOSUKE HOSOGI, MASAHIRO TAKAHASHI, MARI FUKUDA and HISANORI KANI

In Vivo September 2024, 38 (5) 2335-2340; DOI: https://doi.org/10.21873/invivo.13699

Main menu

User menu

Search

COVID-19

Pages